1. Home
  2. OCSL vs TXG Comparison

OCSL vs TXG Comparison

Compare OCSL & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCSL
  • TXG
  • Stock Information
  • Founded
  • OCSL 2007
  • TXG 2012
  • Country
  • OCSL United States
  • TXG United States
  • Employees
  • OCSL N/A
  • TXG N/A
  • Industry
  • OCSL Finance: Consumer Services
  • TXG Biotechnology: Laboratory Analytical Instruments
  • Sector
  • OCSL Finance
  • TXG Industrials
  • Exchange
  • OCSL Nasdaq
  • TXG Nasdaq
  • Market Cap
  • OCSL 1.3B
  • TXG 1.1B
  • IPO Year
  • OCSL 2008
  • TXG 2019
  • Fundamental
  • Price
  • OCSL $14.45
  • TXG $10.09
  • Analyst Decision
  • OCSL Hold
  • TXG Buy
  • Analyst Count
  • OCSL 7
  • TXG 15
  • Target Price
  • OCSL $16.00
  • TXG $15.81
  • AVG Volume (30 Days)
  • OCSL 525.5K
  • TXG 3.7M
  • Earning Date
  • OCSL 07-31-2025
  • TXG 08-07-2025
  • Dividend Yield
  • OCSL 13.78%
  • TXG N/A
  • EPS Growth
  • OCSL N/A
  • TXG N/A
  • EPS
  • OCSL 0.11
  • TXG N/A
  • Revenue
  • OCSL $353,866,000.00
  • TXG $624,662,000.00
  • Revenue This Year
  • OCSL N/A
  • TXG N/A
  • Revenue Next Year
  • OCSL N/A
  • TXG $5.70
  • P/E Ratio
  • OCSL $132.91
  • TXG N/A
  • Revenue Growth
  • OCSL N/A
  • TXG N/A
  • 52 Week Low
  • OCSL $12.50
  • TXG $6.78
  • 52 Week High
  • OCSL $19.80
  • TXG $24.76
  • Technical
  • Relative Strength Index (RSI)
  • OCSL 53.50
  • TXG 62.18
  • Support Level
  • OCSL $13.92
  • TXG $8.95
  • Resistance Level
  • OCSL $14.72
  • TXG $9.79
  • Average True Range (ATR)
  • OCSL 0.24
  • TXG 0.53
  • MACD
  • OCSL 0.01
  • TXG 0.09
  • Stochastic Oscillator
  • OCSL 66.25
  • TXG 95.74

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: